Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ibio Inc (NYSE MKT LLC:IBIO)

0.4047
Delayed Data
As of Apr 21
 -0.0053 / -1.29%
Today’s Change
0.33
Today|||52-Week Range
0.80
+2.46%
Year-to-Date
No recent news for Ibio Inc.

Today’s Trading

Previous close0.41
Today’s open0.42
Day’s range0.40 - 0.42
Volume26,503
Average volume (3 months)114,058
Market cap$36.1M
Dividend yield--
Data as of 4:00pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-48.78%
P/E ratioNM
Price/Sales61.50
Price/Book3.63

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc-0.14-5.41%
ISRIsoRay Inc+0.02+3.54%
BVXVBiondVax Pharmaceuti...-0.29-4.43%
CYANCyanotech Corp0.000.00%
Data as of 4:02pm ET, 04/21/2017

Financials

Last reporting dateAugust 29, 2012
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$948.0K
Annual profit (last year)-$9.8M
Net profit margin-1,029.96%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Robert B. Kay
President
Robert L. Erwin
Corporate headquarters
Newark, Delaware

Forecasts


Search for Jobs